Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria

Details 詳細情報について

• CRID

  1363107368333125248

• DOI

  10.1016/j.jaip.2015.11.025

• ISSN

  22132198

• Web Site

  https://api.elsevier.com/content/article/PII:S2213219815006686?httpAccept=text/plain

  https://api.elsevier.com/content/article/PII:S2213219815006686?httpAccept=text/xml

• Data Source

  • Crossref